Parent and group
- PALATINE100%
PHARMACIE DES PAGODES
ActiveSummary
PHARMACIE DES PAGODES has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €11,549 and a net result of €2,425, of which €3,145 non-recurring income. Equity has been shrinking by about 32% per year since 2018. Its solvency ranks better than 14% of 94 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Overview
Official details
Source: KBO- Status
- Active since 05-09-2005 Normal situation
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21100and 5 others
- Establishment unit
- 2.149.450.813 1020 Brussel, since 14-10-2005
- Financial year end
- 31 December
- Peppol
- Reachable since 19-12-2025
Board and ownership
Board
- BLUESTONEManaging director · permanent representative Paul Ransart
- HARFANGDirector · since 28-04-2023
- PHARMACOAH SRLDirector · since 28-04-2023
Shareholders
- Europhar100%· score 812025 annual accounts of Europhar
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.8%
Annual accounts 2025
- Gross margin
- €152,066
- ▼ 4.4%
- Turnover
- ≈ €390,000
- estimated
- Profit
- €2,425
- Equity
- €11,549
- ▲ 26.6%
- Total assets
- €383,064
- ▲ 10.6%
- Employees on 31-12-2025
- 2
- ▼ 33.3%
- 2025 accounts filed 31 days after the deadline
Filed on 31-08-2026
Score breakdownraises riskLast filed accounts filed 31 days late; 2 of the last 3 accounts lateEquity €11,549 (3.0% of total assets)lowers riskFounded in 2005Legal form: public limited companyShow the evidence
Checked score
Score 2025
68
/ 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 45% of micro companies in pharmaceuticals (NACE 21)
Financial strength · tick: 2024
Weak
Solvency
28=
equity 3.0% of total assets
Liquidity
18+14
short-term debt 96.8% · cash 14.5%
Profitability
70+67
return on assets 0.6%
Bankruptcy probability within 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 4.2%
01-2025: 5.2%▲ +1.0 percentage point vs 12-2024highest value
02-2025: 5.2%● unchanged vs 01-2025highest value
03-2025: 5.1%▼ -0.1 percentage points vs 02-2025
04-2025: 5.1%● unchanged vs 03-2025
05-2025: 5.0%▼ -0.1 percentage points vs 04-2025
06-2025: 2.8%▼ -2.2 percentage points vs 05-2025
07-2025: 3.0%▲ +0.2 percentage points vs 06-2025
08-2025: 3.2%▲ +0.2 percentage points vs 07-2025
09-2025: 3.3%▲ +0.1 percentage points vs 08-2025
10-2025: 2.5%▼ -0.8 percentage points vs 09-2025
11-2025: 2.5%● unchanged vs 10-2025
12-2025: 2.5%● unchanged vs 11-2025
01-2026: 2.5%● unchanged vs 12-2025
02-2026: 2.5%● unchanged vs 01-2026
03-2026: 2.5%● unchanged vs 02-2026
04-2026: 2.5%● unchanged vs 03-2026
05-2026: 2.5%● unchanged vs 04-2026
06-2026: 2.3%▼ -0.2 percentage points vs 05-2026
07-2026: 2.4%▲ +0.1 percentage points vs 06-2026
08-2026: 2.6%▲ +0.2 percentage points vs 07-2026
09-2026: 0.8%▼ -1.8 percentage points vs 08-2026lowest value
10-2026: 0.8%● unchanged vs 09-2026lowest value
11-2026: 0.8%● unchanged vs 10-2026lowest value
Credit of up to €500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.92 (0.84 in 2024), below 1. Short-term debt is 96.8% and cash 14.5% of total assets. 97% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro). It does better than 29% of them on solvency, 16% on liquidity, 56% on profitability and 78% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 94 sector peers (2025).
NBB · sector comparisonPosition among 94 sector peers
Solvency
better than 14%
← weakest
strongest →
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
31 days late
2024
29 days late
2023
138 days late
2022
100 days late
2021
211 days late
2020
80 days late
2019
245 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 119 days after the deadline. In the sector (NACE 21), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 November (4 of the last 5 accounts filed within 71 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
Key points
Recent changes
- · Gazette deed Resignation: PHARMAACH (director)Permanent representative: Stéphanie THOMAES · Appointment: PALATINE (director)
- · Gazette deed Purpose · Amendment of the articles
- · Gazette deed Registered office moved from Bruxelles to GenappeResignations: EUROPHAR (director) and Valérie WERA (director) · Permanent representatives: Patrick Wera, Paul Ransart and Stéphanie Thomaes · Appointments: BLUESTONE, PHARMACOACH and HARFANG
Companies linked to PHARMACIE DES PAGODES
Comparable companies
These companies have the same main activity as PHARMACIE DES PAGODES: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21100). They are comparable in size and age: total assets between €493,000 and €1.3m, founded between 2007 and 2015.
| Company | Total assets | Gross margin |
|---|---|---|
| PHARMACIE DES PAGODES Genappe | €0.4m | €0.2m |
| SOBEGAPHARMA Mons | €1.0m | €0.2m |
| Pharmacie BIHAIN Trois-Ponts | €0.6m | €0.2m |
| D2S Pharma Oudenaarde | €0.6m | €0.1m |
| PHARMACIE DE GIVRY Quévy | €1.3m | €0.5m |
| bioprojet benelux Sint-Jans-Molenbeek | €0.7m | €1.3m |
| PHARMA MAR Brussel | €0.5m | €0.7m |
Key facts about PHARMACIE DES PAGODES
- What is the company number of PHARMACIE DES PAGODES?
- The company number of PHARMACIE DES PAGODES is 0875.872.386. The VAT number is the same number with BE in front: BE 0875.872.386.
- Where is PHARMACIE DES PAGODES based?
- The registered office is at Rue des Lilas 1, 1470 Genappe.Company details
- What does PHARMACIE DES PAGODES do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21100).
- What is the legal form of PHARMACIE DES PAGODES?
- The legal form of PHARMACIE DES PAGODES is Public limited company (NV).
- When was PHARMACIE DES PAGODES founded?
- PHARMACIE DES PAGODES was founded on 05-09-2005.
- Is PHARMACIE DES PAGODES still active?
- Yes, PHARMACIE DES PAGODES is an active enterprise in the KBO register.
- How many employees does PHARMACIE DES PAGODES have?
- PHARMACIE DES PAGODES had an average of 1.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of PHARMACIE DES PAGODES?
- The turnover in financial year 2025 is ≈ €390,000. This figure is estimated from the gross margin of €152,066 and 1,647 comparable companies of the same size. It probably lies between €240,000 and €730,000. It is a rough estimate. In financial year 2019 turnover was €886,566.
- Is PHARMACIE DES PAGODES profitable?
- In financial year 2025, PHARMACIE DES PAGODES made a profit of €2,425.
- Where can I find the annual accounts of PHARMACIE DES PAGODES?
- PHARMACIE DES PAGODES filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMACIE DES PAGODES due?
- PHARMACIE DES PAGODES must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.BLUESTONE · 11 companies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.